Valuation: Acarix AB

Market Cap 243M 24.52M 21.51M 20.32M 18.52M 34.66M 2.35B 34.91M 94.17M 1.2B 92.05M 90.06M 3.86B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 243M 24.52M 21.51M 20.32M 18.52M 34.66M 2.35B 34.91M 94.17M 1.2B 92.05M 90.06M 3.86B EV / Sales 2026 *
17.4x
EV / Sales 2027 * 7.6x
Free-Float
89.13%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%+4.45%+31.82%-18.21% 18.65B
-5.20%-1.26%-40.28%+23.38% 1.85B
0.00%+0.41%-30.18%+23.60% 866M
+0.03%-0.08%+54.47%-2.61% 778M
+0.65%+1.88%-59.22%-84.88% 733M
-0.69%+8.32%-30.46%-46.60% 686M
+1.77%+5.45%-38.77%-51.24% 589M
-0.09%+9.45%+40.21%+90.50% 476M
+5.05%+7.11%-0.46%+9.25% 399M
Average +0.02%+2.21%-8.10%-6.31% 2.78B
Weighted average by Cap. -2.02%+5.29%+18.67%-14.21%

Financials

2026 *2027 *
Net sales 14M 1.41M 1.24M 1.17M 1.07M 2M 135M 2.01M 5.42M 69.12M 5.3M 5.19M 222M 32M 3.23M 2.83M 2.67M 2.44M 4.56M 309M 4.59M 12.39M 158M 12.11M 11.85M 508M
Net income -30.8M -3.11M -2.73M -2.57M -2.35M -4.39M -298M -4.42M -11.93M -152M -11.66M -11.41M -489M -15.3M -1.54M -1.35M -1.28M -1.17M -2.18M -148M -2.2M -5.93M -75.54M -5.79M -5.67M -243M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
-